Lipaglyn (Saroglitazar) is a medication primarily used to manage diabetic dyslipidemia and hypertriglyceridemia. Regarding its effect on creatinine levels:

• Creatinine Levels: There is no strong evidence that Saroglitazar significantly increases creatinine levels. However, as with many medications affecting metabolism and kidney function, monitoring kidney parameters is advisable.

• Kidney Function Monitoring: If you are on Lipaglyn, your doctor may recommend periodic blood tests to check kidney function, including serum creatinine, to ensure safety.

• Consult Your Doctor: If you notice any symptoms like swelling, decreased urine output, or unusual fatigue, inform your healthcare provider promptly.

Overall, while Lipaglyn is not commonly associated with increased creatinine, regular monitoring is important to detect any changes early and maintain kidney health. Please consult your endocrinologist or nephrologist for personalized advice and monitoring.